Cannara Biotech (OTCMKTS:CNBTF) Shares Climb 0.9% – Still a Buy?

Cannara Biotech (OTCMKTS:CNBTF – Get Free Report)’s stock price was up 0.9% during mid-day trading on Thursday. The company traded as high as $1.56 and last traded at $1.5140. 57,000 shares traded hands during mid-day trading, an increase of 72% from the average daily volume of 33,127 shares. The stock had previously closed at $1.50.

Cannara Biotech Stock Performance

The business’s 50 day moving average price is $1.41 and its 200 day moving average price is $1.32.

Get Cannara Biotech alerts:

Cannara Biotech Inc (OTCMKTS:CNBTF) is a Canadian cannabis company focused on the cultivation, processing and sale of indoor-grown cannabis and cannabis products. The company operates as a vertically integrated business, managing activities across cultivation, manufacturing, product development and distribution.

Cannara produces a range of cannabis offerings, including dried flower, pre-rolls, cannabis concentrates, hash, vaporizers and other cannabis-derived products. Its portfolio includes brands such as Tribal, Nugz and Orchid CBD, which are marketed through Canada’s regulated cannabis channels.

The company is based in Quebec and serves the Canadian cannabis market.

See Also

• Five stocks we like better than Cannara Biotech
• Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
• Paychex Plunges, Providing the Entry Investors Have Been Waiting For
• The Case for Buying High-Yield General Mills Just Strengthened
• SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story

Receive News & Ratings for Cannara Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannara Biotech and related companies with MarketBeat.com's FREE daily email newsletter.